Under DKD pathological conditions, factors such as hyperglycemia and renin-angiotensin system (RAS) activation stimulate the production of TGF-β1 in tubular cells, podocytes, mesangial cells, and glomerular endothelial cells (9–12). Here, TGFB1 is linked to diabetic kidney disease.